Table 1 Summary of studies investigating the presence of SARS-CoV-2 in semen samples
| Study | Disease stage | No. of semen samples | Interval from diagnosis/ test sample | SARS CoV-2 (−) RT PCR samples | SARS CoV-2 (+) RT PCR samples | |
|---|---|---|---|---|---|---|
| Song et al. [68] | Recovering man | 12 | 1 Testesa | N/A | 100% (13/13) | 0 |
| Guo et al. [62] | Recent/recovering | 23 | Median 32 days | 100% (23/23) | 0 | |
| Pan et al. [42] | Recovering | 34 | Median 31 days | 100% (34/34) | 0 | |
| Kayaaslan et al. [69] | Hospitalized patients in acute stage | 16 | Median 1 day | 100% (16/16) | 0 | |
|
Holtman et al. [61] Cohort study | 16 recovered/2 acute phase of infection | 18 | 8–54 days after absence of symptoms | 100% (18/18) | 0 | |
| Zhang et al. [70] | 3 positive/7 recovering | 10 expressed prostatic secretion | < 3 days after positive test, 1 day after SARS Cov-2 (−) test | 100% 10/10 | 0 | |
| Li D et al. [71] | 15 acute phase of infection + 23 recovered | 38 |
Acute phase 6–11 days from symptoms onset, 2–3 days after clinical recovery |
84% (32/38) (13/15 + 19/23) |
16% (6/38) (4/15 + 2/23) | |